Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Recalcitrant pemphigus vulgaris: aseptic meningitis associated with intravenous immunoglobulin therapy and successful treatment with rituximab.

Ventura F, Rocha J, Fernandes JC, Machado A, Brito C.

Int J Dermatol. 2013 Apr;52(4):501-2. doi: 10.1111/j.1365-4632.2010.04870.x. Epub 2013 Mar 3. No abstract available.

PMID:
23451774
2.

Is it time to re-evaluate the treatment of pemphigus?

Leventhal JS, Sanchez MR.

J Drugs Dermatol. 2012 Oct;11(10):1200-6.

PMID:
23134985
3.

Childhood pemphigus vulgaris successfully treated with rituximab.

Kanwar AJ, Sawatkar GU, Vinay K, Hashimoto T.

Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):632-4. doi: 10.4103/0378-6323.100587.

4.

Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.

Mullane D, Williams L, Merwick A, Tobin WO, McGuigan C.

Ir Med J. 2012 Jun;105(6):182-3.

PMID:
22973657
5.

Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.

Kim MR, Kim HC, Kim SC.

Dermatology. 2011;223(2):182-8. doi: 10.1159/000332848. Epub 2011 Oct 21.

PMID:
22025028
6.

Human intravenous immunoglobulin-induced aseptic meningitis: a case report.

Chaabane A, Hamzaoui A, Aouam K, Klai R, Fredj NB, Boughattas NA, Mahjoub S.

J Clin Pharmacol. 2012 Feb;52(2):279-81. doi: 10.1177/0091270010394183. No abstract available.

PMID:
21257801
7.

Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.

Matsukura S, Knowles SR, Walsh S, Shear NH.

Arch Dermatol. 2012 Jun;148(6):734-9. doi: 10.1001/archdermatol.2011.3320. Erratum in: Arch Dermatol. 2012 Sep 1;148(9):1012. Dosage error in article text. Arch Dermatol. 2012 Aug;148(8):970. Dosage error in article text.

PMID:
22351790
8.

Current therapy of the pemphigus group.

Kasperkiewicz M, Schmidt E, Zillikens D.

Clin Dermatol. 2012 Jan-Feb;30(1):84-94. doi: 10.1016/j.clindermatol.2011.03.014. Review.

PMID:
22137231
9.

Treatment of severe pemphigus vulgaris of the scalp with adjuvant rituximab and immunoadsorption.

Kamphausen I, Schulze F, Schmidt E, Zillikens D, Kunz M.

Eur J Dermatol. 2012 Nov-Dec;22(6):786-7. doi: 10.1684/ejd.2012.1843. No abstract available.

PMID:
23114083
10.

[[Treatment of therapy resistant pemphigus vulgaris with rituximab and immunoglobulins].

Mühlhoff C, Megahed M.

Hautarzt. 2007 Nov;58(11):924-6. German. No abstract available.

PMID:
17952393
11.

Adjuvant rituximab in the treatment of pemphigus vulgaris: a phase II clinical trial.

Balighi K, Daneshpazhooh M, Khezri S, Mahdavi-nia M, Hajiseyed-javadi M, Chams-Davatchi C.

Int J Dermatol. 2013 Jul;52(7):862-7. doi: 10.1111/j.1365-4632.2012.5847.x. Erratum in: Int J Dermatol. 2013 Oct;52(10):1292. Kamran, Balighi [corrected to Balighi, Kamran]; Maryam, Daneshpazhooh [corrected to Daneshpazhooh, Maryam]; Somayeh, Khezri [corrected to Khezri, Somayeh]; Mostafa, Mahdavi-nia [corrected to Mahdavi-nia, Mostafa]; Mahsa, Hajiseyed-javadi [corrected to Hajiseyed-javadi, Mahsa]; Cheyda, Chams-Davatchi [corrected to Chams-Davatchi, Cheyda].

PMID:
23789604
12.

[Effectiveness and safety of rituximab in pemphigus vulgaris].

Alonso Sánchez A, García Rodríguez S, López Avila A, Rabell Iñigo S.

Farm Hosp. 2010 Mar-Apr;34(2):98-9. doi: 10.1016/j.farma.2009.10.002. Epub 2010 Feb 2. Spanish. No abstract available.

PMID:
20304370
13.

Rituximab in pemphigus.

Kanwar AJ, Vinay K.

Indian J Dermatol Venereol Leprol. 2012 Nov-Dec;78(6):671-6. doi: 10.4103/0378-6323.102354. No abstract available.

14.

Rituximab for pemphigus vulgaris.

Joly P, D'Incan M, Musette P.

N Engl J Med. 2007 Feb 1;356(5):521; author reply 521-2. No abstract available.

15.

Long-Term Remissions in Recalcitrant Pemphigus Vulgaris.

Ahmed AR, Kaveri S, Spigelman Z.

N Engl J Med. 2015 Dec 31;373(27):2693-4. doi: 10.1056/NEJMc1508234. No abstract available.

16.

Comparison of immunological parameters in patients with pemphigus vulgaris following rituximab and IVIG therapy.

Feldman RJ, Christen WG, Ahmed AR.

Br J Dermatol. 2012 Mar;166(3):511-7. doi: 10.1111/j.1365-2133.2011.10658.x. Epub 2012 Jan 19.

PMID:
21967407
17.

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin.

Ahmed AR, Spigelman Z, Cavacini LA, Posner MR.

N Engl J Med. 2006 Oct 26;355(17):1772-9.

18.

Management of pemphigus in pediatric patients.

Gürcan H, Mabrouk D, Razzaque Ahmed A.

Minerva Pediatr. 2011 Aug;63(4):279-91. Review.

PMID:
21909064
19.

Acquired haemophilia treated successfully with rituximab in a patient with pemphigus vulgaris.

Chiba T, Tsuji G, Mitoma H, Takahara M, Moroi Y, Miyamoto T, Furue M.

Haemophilia. 2013 Mar;19(2):e98-9. doi: 10.1111/hae.12087. No abstract available.

PMID:
23419110
20.

Treatment strategies for pemphigus vulgaris in Japan.

Hashimoto T.

Expert Opin Pharmacother. 2008 Jun;9(9):1519-30. doi: 10.1517/14656566.9.9.1519 . Review.

PMID:
18518782

Supplemental Content

Support Center